AUM Cardiovascular said last week it completed enrollment for the pivotal study of its CADence handheld heart disease diagnostics device. Aum’s Cadence is designed to identify obstructions in the coronary arteries by detecting acoustic signals generated by the turbulence created as blood flows past the obstruction, according to the company’s site. The company’s name is based on a […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
LoneStar Heart touts 1-year Algisyl data
LoneStar Heart yesterday presented 1-year data from a follow-up study of its Algisyl hydrogel cardiac implant designed to treat patients with failing heart muscle. The presentation was made at the American Heart Association’s annual meeting in Orlando and published in the European Journal of Heart Failure. Algisyl is a novel inert hydrogel that is designed to be […]
Boston Scientific dips on Medicare reimbursement hit for Watchman anti-stroke device
Boston Scientific (NYSE:BSX) shares took a hit yesterday after a Centers for Medicare & Medicaid Services proposal that would limit coverage for the Watchman anti-stroke device. Investors also likely reacted to a pair of Class II recalls from the FDA, sending BSX shares down -4.2% to $18.01 apiece yesterday. Watchman, a transcatheter implant designed to seal off […]
Boston Scientific touts Watchman study data
Boston Scientific (NYSE:BSX) yesterday presented data on its Watchman left atrial appendage occlusion device. The data was presented at the annual American Heart Association’s Scientific Sessions in Orlando, Fla. The data comes from the Ewolution registry, the 1st real-world study of the Marlborough, Mass.-based company’s Watchman device. The patient population of the study was the ‘highest […]
Xeltis completes 2nd feasibility trial of cardiac valve system
Xeltis said today it completed its 2nd feasibility trial of its bioabsorbable regenerative heart valve technology designed to allow endogenous tissue restoration. The Swiss med tech firm is designing valves and vessels out of polymers structured as a “porous matrix” designed to be absorbed and leave the patient with its own healthy tissue, the company […]
Study shows advantages of mitral valve replacement over repair
(Reuters) — Patients with severe leakage from the mitral valve of the heart who had the valve replaced had significantly lower rates of recurrence and heart failure two years after the procedure than those who underwent surgical repair, according to data presented on Monday. Mitral valve regurgitation, in which blood leaks backward through the valve […]
Glaukos touts 3-year data from iStent trial
Glaukos (NYSE:GKOS) today released data from a 3-year study of its iStent travecular micro-bypass stent, touting sustained reductions in intra-ocular pressure after treatment with 2 of the devices. The study was published in the November issue of the Clinical Ophtalmology journal, the company said. The iStent trabecular micro-bypass stent is a tiny titanium stent designed to […]
Medtronic’s Micra pacer trial meets endpoints
Medtronic‘s (NYSE:MDT) entry into the micro-sized leadless pacemaker market has met its primary safety and effectiveness endpoints with “wide margins,” the company said today. The Micra transcatheter pacing system, which at 1/10th the size of a conventional pacemaker is roughly the size of a large vitamin, is designed to be implanted via catheter in the […]
Study: Lower hospitalization rates for St. Jude Medical’s CardioMEMS heart failure monitor
St. Jude Medical (NYSE:STJ) put another brick in the wall of its defense of the CardioMEMS heart failure monitor, which was assailed earlier this year by claims that the device is not cost-effective. New data from the St. Paul, Minn.-based company’s 550-patient Champion trial, published online yesterday in The Lancet, showed lower hospitalization rates for patients treating using […]
VIVA 2015 Roundup: Medtronic touts Valiant stent graft, PAD stent-treatment data
Medtronic (NYSE:MDT) this week presented data from 2 studies of its stent systems and announced a new study of its In.Pact Admiral drug-coated balloon. The announcements were made at the VIVA physicians annual conference in Las Vegas, Nev. The Fridley, Minn.-based medical giant presented data from a 2-year clinical trial of its Valiant Captivia thoracic stent graft […]
MC3 Cardiopulmonary picks up Terumo cannula assets
MC3 Cardiopulmonary said it acquired Terumo Corp.‘s (TYO:4543) surgical cannula assets, including its branded Sarns Soft-Flow arterial cannula. Dexter, Mich.-based MC3 Cardiopulmonary spun-out of the University of Michigan in 1991 and focuses on heart and lung extracorporeal life support research, the company said. “This is a significant milestone for us, and we are excited to […]